Ossur Hf : Interim report Q1 2019

04:00 EDT 30 Apr 2019 | GlobalNewsWire (2014)
This article has expired, however you can still download the PDF.
Announcement no. 28/2019Interim report Q1 201930 April 2019 Highlights Sales growth of 19% in local currency in the quarter and organic sales growth of 8%.  The prosthetics segment grew 10% organic and the B&S segment grew 5% organic. ...

Other Sources for this Article


More From BioPortfolio on "Ossur Hf : Interim report Q1 2019"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...